SuperworthNovoCure market cap NVCR
Share price times shares outstanding: what the whole company sells for, since 2015.
- Today, Oct 23, 2026
- $1.7B
- Highest close in our data
- $22.9B
- Jun 2021
NovoCure is worth $1.7B at the close on Oct 23, 2026, at $14.68 a share.
That is up 11% over the last year and down 84% over five years.
Its highest close in our data was $22.9B in Jun 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.7B | $1.1B | $2.1B | +13% |
| 2025 | $1.5B | $1.2B | $3.3B | −55% |
| 2024 | $3.3B | $1.3B | $3.6B | +108% |
| 2023 | $1.6B | $1.2B | $11.4B | −79% |
| 2022 | $7.7B | $6.1B | $9.3B | −1% |
| 2021 | $7.8B | $7.8B | $22.9B | −56% |
| 2020 | $17.6B | $5.9B | $17.6B | +103% |
| 2019 | $8.7B | $3.1B | $9.3B | +184% |
| 2018 | $3.1B | $1.7B | $4.9B | +69% |
| 2017 | $1.8B | $542.4M | $1.9B | +165% |
| 2016 | $681.2M | $524.9M | $1.7B | −64% |
| 2015 | $1.9B | $1.8B | $2.3B | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest NovoCure's size, closest first, today.
| Company | Market cap |
|---|---|
| NVCRNovoCure | $1.7B |
| LMATLemaitre Vascular | $1.9B |
| EYENational Vision | $1.5B |
| INSPInspire Medical Systems | $2.1B |
| CDRECadre | $1.3B |
| UFPTUFP Technologies | $2.3B |
| BVSBioventus | $1.3B |
| STAAStaar Surgical | $1.1B |
| IRMDIradimed | $1.1B |
| ATRCAtriCure | $3B |
| WRBYWarby Parker | $3.2B |
| Peer median | $1.7B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on NovoCure
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.